Free Trial

Strata Critical Medical (SRTA) Competitors

$5.43 0.00 (0.00%)
Closing price 06/12/2026 04:00 PM Eastern
Extended Trading
$5.30 -0.13 (-2.30%)
As of 06/12/2026 06:46 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

SRTA vs. LPG, FLNG, LIND, NVGS, and GSL

Should you buy Strata Critical Medical stock or one of its competitors? MarketBeat compares Strata Critical Medical with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Strata Critical Medical include Dorian LPG (LPG), Flex LNG (FLNG), Lindblad Expeditions (LIND), Navigator (NVGS), and Global Ship Lease (GSL). These companies are all part of the "transportation" industry.

How does Strata Critical Medical compare to Dorian LPG?

Strata Critical Medical (NASDAQ:SRTA) and Dorian LPG (NYSE:LPG) are both small-cap transportation companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, profitability, analyst recommendations, media sentiment, dividends, institutional ownership, valuation and risk.

Strata Critical Medical currently has a consensus target price of $8.00, indicating a potential upside of 47.33%. Dorian LPG has a consensus target price of $55.00, indicating a potential upside of 21.86%. Given Strata Critical Medical's stronger consensus rating and higher possible upside, analysts clearly believe Strata Critical Medical is more favorable than Dorian LPG.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Strata Critical Medical
0 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
2.75
Dorian LPG
0 Sell rating(s)
3 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.50

In the previous week, Strata Critical Medical had 6 more articles in the media than Dorian LPG. MarketBeat recorded 6 mentions for Strata Critical Medical and 0 mentions for Dorian LPG. Dorian LPG's average media sentiment score of 0.00 beat Strata Critical Medical's score of -0.36 indicating that Dorian LPG is being referred to more favorably in the news media.

Company Overall Sentiment
Strata Critical Medical Neutral
Dorian LPG Neutral

Strata Critical Medical has a beta of 2.2, meaning that its stock price is 120% more volatile than the broader market. Comparatively, Dorian LPG has a beta of 0.62, meaning that its stock price is 38% less volatile than the broader market.

47.4% of Strata Critical Medical shares are owned by institutional investors. Comparatively, 62.5% of Dorian LPG shares are owned by institutional investors. 15.5% of Strata Critical Medical shares are owned by company insiders. Comparatively, 13.6% of Dorian LPG shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Dorian LPG has higher revenue and earnings than Strata Critical Medical. Strata Critical Medical is trading at a lower price-to-earnings ratio than Dorian LPG, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Strata Critical Medical$228.58M2.06$41.35M-$0.08N/A
Dorian LPG$481.51M4.01$193.67M$4.559.92

Dorian LPG has a net margin of 40.22% compared to Strata Critical Medical's net margin of 20.56%. Dorian LPG's return on equity of 18.01% beat Strata Critical Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Strata Critical Medical20.56% -4.06% -3.49%
Dorian LPG 40.22%18.01%10.86%

Summary

Dorian LPG beats Strata Critical Medical on 11 of the 17 factors compared between the two stocks.

How does Strata Critical Medical compare to Flex LNG?

Flex LNG (NYSE:FLNG) and Strata Critical Medical (NASDAQ:SRTA) are both small-cap transportation companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, dividends, profitability, earnings, media sentiment, valuation and risk.

Flex LNG has a net margin of 22.26% compared to Strata Critical Medical's net margin of 20.56%. Flex LNG's return on equity of 12.15% beat Strata Critical Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Flex LNG22.26% 12.15% 3.37%
Strata Critical Medical 20.56%-4.06%-3.49%

Flex LNG currently has a consensus target price of $24.00, suggesting a potential downside of 23.20%. Strata Critical Medical has a consensus target price of $8.00, suggesting a potential upside of 47.33%. Given Strata Critical Medical's stronger consensus rating and higher possible upside, analysts plainly believe Strata Critical Medical is more favorable than Flex LNG.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Flex LNG
2 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.50
Strata Critical Medical
0 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
2.75

Flex LNG has higher revenue and earnings than Strata Critical Medical. Strata Critical Medical is trading at a lower price-to-earnings ratio than Flex LNG, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Flex LNG$347.64M4.86$74.82M$1.4022.32
Strata Critical Medical$228.58M2.06$41.35M-$0.08N/A

In the previous week, Strata Critical Medical had 6 more articles in the media than Flex LNG. MarketBeat recorded 6 mentions for Strata Critical Medical and 0 mentions for Flex LNG. Flex LNG's average media sentiment score of 0.00 beat Strata Critical Medical's score of -0.36 indicating that Flex LNG is being referred to more favorably in the media.

Company Overall Sentiment
Flex LNG Neutral
Strata Critical Medical Neutral

Flex LNG has a beta of 0.18, meaning that its share price is 82% less volatile than the broader market. Comparatively, Strata Critical Medical has a beta of 2.2, meaning that its share price is 120% more volatile than the broader market.

47.4% of Strata Critical Medical shares are owned by institutional investors. 0.3% of Flex LNG shares are owned by insiders. Comparatively, 15.5% of Strata Critical Medical shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Summary

Flex LNG beats Strata Critical Medical on 9 of the 17 factors compared between the two stocks.

How does Strata Critical Medical compare to Lindblad Expeditions?

Strata Critical Medical (NASDAQ:SRTA) and Lindblad Expeditions (NASDAQ:LIND) are both small-cap transportation companies, but which is the better business? We will compare the two companies based on the strength of their profitability, risk, institutional ownership, media sentiment, earnings, valuation, dividends and analyst recommendations.

In the previous week, Strata Critical Medical had 2 more articles in the media than Lindblad Expeditions. MarketBeat recorded 6 mentions for Strata Critical Medical and 4 mentions for Lindblad Expeditions. Lindblad Expeditions' average media sentiment score of 0.71 beat Strata Critical Medical's score of -0.36 indicating that Lindblad Expeditions is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Strata Critical Medical
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Lindblad Expeditions
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

Strata Critical Medical has higher earnings, but lower revenue than Lindblad Expeditions. Strata Critical Medical is trading at a lower price-to-earnings ratio than Lindblad Expeditions, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Strata Critical Medical$228.58M2.06$41.35M-$0.08N/A
Lindblad Expeditions$771.02M1.99-$29.72M-$0.54N/A

Strata Critical Medical has a beta of 2.2, suggesting that its share price is 120% more volatile than the broader market. Comparatively, Lindblad Expeditions has a beta of 2.26, suggesting that its share price is 126% more volatile than the broader market.

47.4% of Strata Critical Medical shares are held by institutional investors. Comparatively, 75.9% of Lindblad Expeditions shares are held by institutional investors. 15.5% of Strata Critical Medical shares are held by company insiders. Comparatively, 26.1% of Lindblad Expeditions shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Strata Critical Medical has a net margin of 20.56% compared to Lindblad Expeditions' net margin of -2.86%. Lindblad Expeditions' return on equity of 0.00% beat Strata Critical Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Strata Critical Medical20.56% -4.06% -3.49%
Lindblad Expeditions -2.86%N/A -0.44%

Strata Critical Medical currently has a consensus price target of $8.00, suggesting a potential upside of 47.33%. Lindblad Expeditions has a consensus price target of $24.33, suggesting a potential upside of 3.77%. Given Strata Critical Medical's stronger consensus rating and higher probable upside, equities research analysts plainly believe Strata Critical Medical is more favorable than Lindblad Expeditions.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Strata Critical Medical
0 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
2.75
Lindblad Expeditions
1 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.50

Summary

Lindblad Expeditions beats Strata Critical Medical on 9 of the 17 factors compared between the two stocks.

How does Strata Critical Medical compare to Navigator?

Strata Critical Medical (NASDAQ:SRTA) and Navigator (NYSE:NVGS) are both small-cap transportation companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, profitability, risk, dividends, earnings, media sentiment and valuation.

Strata Critical Medical has a net margin of 20.56% compared to Navigator's net margin of 18.84%. Navigator's return on equity of 7.01% beat Strata Critical Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Strata Critical Medical20.56% -4.06% -3.49%
Navigator 18.84%7.01%3.80%

Strata Critical Medical presently has a consensus target price of $8.00, suggesting a potential upside of 47.33%. Navigator has a consensus target price of $23.33, suggesting a potential upside of 1.39%. Given Strata Critical Medical's higher probable upside, equities research analysts plainly believe Strata Critical Medical is more favorable than Navigator.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Strata Critical Medical
0 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
2.75
Navigator
0 Sell rating(s)
1 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.83

In the previous week, Strata Critical Medical had 5 more articles in the media than Navigator. MarketBeat recorded 6 mentions for Strata Critical Medical and 1 mentions for Navigator. Navigator's average media sentiment score of 1.82 beat Strata Critical Medical's score of -0.36 indicating that Navigator is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Strata Critical Medical
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Navigator
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

47.4% of Strata Critical Medical shares are held by institutional investors. Comparatively, 19.0% of Navigator shares are held by institutional investors. 15.5% of Strata Critical Medical shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Strata Critical Medical has a beta of 2.2, indicating that its share price is 120% more volatile than the broader market. Comparatively, Navigator has a beta of 0.44, indicating that its share price is 56% less volatile than the broader market.

Navigator has higher revenue and earnings than Strata Critical Medical. Strata Critical Medical is trading at a lower price-to-earnings ratio than Navigator, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Strata Critical Medical$228.58M2.06$41.35M-$0.08N/A
Navigator$586.96M2.42$100.12M$1.6314.12

Summary

Navigator beats Strata Critical Medical on 10 of the 17 factors compared between the two stocks.

How does Strata Critical Medical compare to Global Ship Lease?

Strata Critical Medical (NASDAQ:SRTA) and Global Ship Lease (NYSE:GSL) are both small-cap transportation companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, institutional ownership, analyst recommendations, dividends, media sentiment, profitability, risk and earnings.

Strata Critical Medical has a beta of 2.2, indicating that its stock price is 120% more volatile than the broader market. Comparatively, Global Ship Lease has a beta of 0.92, indicating that its stock price is 8% less volatile than the broader market.

Strata Critical Medical currently has a consensus price target of $8.00, indicating a potential upside of 47.33%. Global Ship Lease has a consensus price target of $46.50, indicating a potential upside of 16.08%. Given Strata Critical Medical's higher possible upside, research analysts plainly believe Strata Critical Medical is more favorable than Global Ship Lease.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Strata Critical Medical
0 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
2.75
Global Ship Lease
1 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
2.80

47.4% of Strata Critical Medical shares are held by institutional investors. Comparatively, 50.1% of Global Ship Lease shares are held by institutional investors. 15.5% of Strata Critical Medical shares are held by insiders. Comparatively, 7.4% of Global Ship Lease shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Global Ship Lease has a net margin of 50.01% compared to Strata Critical Medical's net margin of 20.56%. Global Ship Lease's return on equity of 21.11% beat Strata Critical Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Strata Critical Medical20.56% -4.06% -3.49%
Global Ship Lease 50.01%21.11%13.42%

In the previous week, Strata Critical Medical and Strata Critical Medical both had 6 articles in the media. Global Ship Lease's average media sentiment score of 1.01 beat Strata Critical Medical's score of -0.36 indicating that Global Ship Lease is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Strata Critical Medical
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Global Ship Lease
3 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Global Ship Lease has higher revenue and earnings than Strata Critical Medical. Strata Critical Medical is trading at a lower price-to-earnings ratio than Global Ship Lease, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Strata Critical Medical$228.58M2.06$41.35M-$0.08N/A
Global Ship Lease$757.04M1.90$416.45M$10.533.80

Summary

Global Ship Lease beats Strata Critical Medical on 11 of the 15 factors compared between the two stocks.

Get Strata Critical Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for SRTA and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SRTA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SRTA vs. The Competition

MetricStrata Critical MedicalAir Transportation IndustryTransportation SectorNASDAQ Exchange
Market Cap$469.84M$1.05B$8.82B$12.05B
Dividend YieldN/AN/A983.12%5.66%
P/E Ratio-67.8810.5625.5624.42
Price / Sales2.061.256.39111.24
Price / CashN/A2.308.6637.92
Price / Book1.691.692.266.82
Net Income$41.35M$196.61M$535.59M$337.56M
7 Day Performance-7.50%-7.51%1.75%1.17%
1 Month Performance4.02%11.33%8.94%3.16%
1 Year PerformanceN/AN/A35.45%30.58%

Strata Critical Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SRTA
Strata Critical Medical
3.1942 of 5 stars
$5.43
flat
$8.00
+47.3%
N/A$469.84M$228.58MN/A130
LPG
Dorian LPG
3.8788 of 5 stars
$43.35
-0.1%
$55.00
+26.9%
+79.7%$1.85B$481.51M9.52540
FLNG
Flex LNG
0.6541 of 5 stars
$30.47
+2.5%
$24.00
-21.2%
+27.1%$1.65B$347.64M21.768
LIND
Lindblad Expeditions
2.1936 of 5 stars
$21.93
-1.5%
$24.33
+11.0%
+121.2%$1.44B$771.02MN/A1,550
NVGS
Navigator
3.8277 of 5 stars
$22.66
+0.3%
$23.33
+3.0%
+57.4%$1.40B$586.96M13.89120

Related Companies and Tools


This page (NASDAQ:SRTA) was last updated on 6/15/2026 by MarketBeat.com Staff.
From Our Partners